Prevalence and Risk Factors of Hypertension in Type 2 Diabetics in Benin

Background: Couple High Blood Pressure (HBP)-Diabetes is a morbid association and a public health problem. The aim of this study was to determine the actual epidemiological profile of HBP in type 2 diabetic. Methods: A cross-sectional, prospective, descriptive and analytical study was conducted at Banque d’insuline of Cotonou, Polyclinique Atinkanmey and CHUD-Ouémé-Plateau. The study took place over a period of 06 months from March 01 to August 30, 2014. The study included patients with type 2 diabetes mellitus seen at consultation who agreed to participate in the study. Results: The survey involved 400 individuals. Among them, 34% were male and the sex ratio was 0.48. The mean age was 55.6 ± 10.3 years (range 28 - 87 years). The prevalence of hypertension in type 2 diabetic patients was 70%. The risk factors significantly associated with HBP were age above 55 years (p = 0.000), abdominal obesity (p = 0.036), a diabetes duration above 10 years (p = 0.009). Complications significantly associated with HBP were stroke (p = 0.013) and diabetic foot (p = 0.044). Conclusion: HBP-type 2 Diabetes association is frequent in Benin.

Prevalence and Risk Factors of Diabetes Mellitus in the Adult Population of Porto-Novo (Benin)

Introduction: The aim of this study was to determine the prevalence and risk factors of diabetes mellitus in the adult population of Porto-Novo. Methods: A cross-sectional study with random sampling, stratified cluster, was used. Fasting blood glucose was measured in capillary blood (Accu-Chek Active). Diabetes mellitus was defined as fasting glucose ≥ 1.26 g/L, and fasting hyperglycemia in non-diabetic fasting glucose ≥ 1.10 and < 1.26 g/L. Results: The survey involved 240 individuals. The sex ratio was 0.48. The mean age was 46 ± 13 years (range 25 - 80 years). The prevalence of hyperglycemic patients was 7.9%. The prevalence of diabetes was 6.7%, including 3.3% of unknown diabetes, half of diabetics. The prevalence of fasting hyperglycemia without diabetes was 1.2%. The risk factors for diabetes type 2 onset were a family history of diabetes (p = 0.017), older age (p = 0.003), hypertension (p = 0.005) and abdominal obesity (NCEP: p = 0.044;FID: p = 0.001). Conclusion: These high figures confirm the increasing prevalence of diabetes mellitus in Benin, documented in many developing countries.

Contribution of the Ambulatory Measure of Blood Pressure (AMBP) to the Detection of Hypertension in Type 2 Diabetic Black African

This paper is to determine the contribution of the ambulatory measure of blood pressure (AMBP) to the detection of hypertension in type 2 diabetic black African in Benin. Hypertension can stay unknown in diabetic patients. Patients and Methods: We conducted a cross-sectional, prospective, descriptive and analytical study at “Banqued’ insuline” of Cotonou, Polyclinique Atinkanmey and CHUD-Ouémé-Plateau. The study took place over a period of 6 months from March 01 to August 30 2014. The study included patients with type 1 or 2 diabetes who agreed to participate in the study and who made ambulatory measure of blood pressure (AMBP). Statistical analysis was done by using the software Excel 2013 and SPSS versus 18.0. Results: Sixty six patients were included. Forty one (62.1%) among them were female;sex-ratio was 0.61. The mean of age was 48.9 ± 8.8 years with range from 30 to 68 years. The prevalence of masked hypertension in type 2 diabetics was 37.9% (25/66). Abdominal obesity was the significative factor related to masked high blood pressure (HBP) in the type 2 diabetics (p = 0.005). Among diabetic with masked hypertension, 14 (56%) had “no dipper” profile and 11 (44%) had “dipper” profile. Conclusion: The ambulatory measure of blood pressure (AMBP) may take an important place in the detection of Hypertension in black type 2 diabetic subjects.

Primary Headache Disorders in HIV-Infected Patients within a Hospital Setting in Sub-Saharan Africa, Benin Case: Prevalence and Associated Factors

Introduction: Headache disorders are common in HIV-infected patients. These disorders are either primary or secondary. Objective: Determine prevalence and factors associated with primary headache disorders in HIV+ patients. Method: It was a cross-sectional, descriptive and analytical study conducted from 2nd May 2017 to 2nd August 2017 which included HIV+ patients aged 18 years and above. Diagnosis of primary headache disorders was carried out by a Neurologist on the basis of ICHD-II diagnostic criteria. The?dependent variable was primary headache disorders. Epi Info Version 7.2.1.0 and STATA11 were used for data analysis. P Results: Primary headache disorders prevalence was 25.2% (124/493).Tension-type headache represented 77.41%. HIV+ patients were aged 42.63 ± 10.14 years. Sex-ratio was estimated at 0.14. Factors associated with primary headache disorders in HIV+ patients were: male (0.36 [0.17 - 0.77];P = 0.008), Dendi ethnicity (14.8 [2.08 - 101.99];P = 0.007), trader (3.09 [01.25 - 7.62];P = 0.02), WHO clinical stage (3.20 [1.43 - 7.17];P = 0.005), screening duration (1.01 [1.00 - 1.01];P = 0.00), hypertension (10.28 [4.44 - 23.83];P ≤ 0.001). Conclusion: This study helped to determine the standard profile of HIV+ patient with primary headache disorders. It will contribute to save costs associated with paraclinical examinations, while in search of secondary etiologies within an African context with limited financial resources.

Late Presentation to Care among People Living with HIV in Cotonou, Benin: A Retrospective Analysis from 2003 to 2014

Background: Late presentation to care is associated with increased morbidity, mortality and healthcare cost. Objectives: To determine the prevalence of late presentation to care in Benin, describe its trends and identify risk factors associated. Methods: We conducted a retrospective analysis from 2003 to 2014 at the National HIV Referral Centre in Benin. The definition of the European Late Presentation Consensus Group (ELPCG) for late presentation to care was used. Late Presenters (LP) were defined as patients presenting to care with CD4 count below 350 cells/mm3 or with an AIDS defining event, and patients with advanced HIV disease (AHD) were defined as persons with a CD4 count below 200 cells/mm3. Results: 5018 patients were included. Women accounted for 62.9%. Patients ranged in age from 18 to 62 years. 4233 patients (84.4%) were late presenters (LP) and 3126 (62.3%) were in Advanced HIV Disease (AHD). Late presentation decreased from 97.7% in 2003 to 78.7% in 2009. Between 2009 and 2014, there was no substantial decrease. Older age [Odds Ratio (OR) = 3.17;95% Confidence Interval (CI) = [2.52 - 4.00], p Conclusions: The prevalence of late presentation to care in Cotonou is alarming. This prevalence has been on a declining trend, but it remains extremely high. In order to reach the first 90 of the 90-90-90 targets, policymakers should promote the Provider-initiated HIV Testing and Counselling in all health facilities, modeled on the existing PMTCT of HIV screening during pregnancy.